These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 6085357)

  • 41. Effects of nicorandil on arterial and venous vessels of the forearm in systemic hypertension.
    Levenson J; Bouthier J; Chau NP; Roland E; Simon AC
    Am J Cardiol; 1989 Jun; 63(21):40J-43J. PubMed ID: 2525324
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intrinsic modifications of the brachial and radial arteries in hypertensive humans.
    Boutouyrie P; Lacolley P; Laurent S; London GM; Safar ME
    Clin Invest Med; 1994 Apr; 17(2):97-106. PubMed ID: 8004855
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Nitrendipine, a new calcium antagonist, as basis therapy in essential hypertension].
    Groth H; Stimpel M; Edmonds D; Mosca R; Vetter W
    Schweiz Rundsch Med Prax; 1985 May; 74(19):503-6. PubMed ID: 3160097
    [No Abstract]   [Full Text] [Related]  

  • 44. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade.
    Warltier DC; Zyvoloski MG; Gross GJ; Brooks HL
    J Pharmacol Exp Ther; 1984 Aug; 230(2):367-75. PubMed ID: 6146711
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Renal and vascular protective effects of cilnidipine in patients with essential hypertension.
    Morimoto S; Yano Y; Maki K; Iwasaka T
    J Hypertens; 2007 Oct; 25(10):2178-83. PubMed ID: 17885563
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of nitrendipine as baseline antihypertensive therapy.
    Rüddel H; Schmieder R; Langewitz W; Neus J; Wagner O; von Eiff AW
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1049-52. PubMed ID: 6085365
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Systemic and regional hemodynamics in normotensive and spontaneously hypertensive rats after slow-channel calcium blocker nitrendipine.
    Sesoko S; Pegram BL; Frohlich ED
    Clin Exp Hypertens A; 1984; 6(5):979-91. PubMed ID: 6733943
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ouabain-induced elevation in forearm vascular resistance, calcium entry and alpha-adrenoceptor blockade, and release and removal of noradrenaline.
    Schulte KL; van Gemmeren D; Thiede HM; Meyer-Sabellek W; Gotzen R; Distler A
    J Hypertens Suppl; 1987 Dec; 5(5):S215-8. PubMed ID: 2895170
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Comparison of isobaric effects of hypertension and diabetes mellitus on geometric and elastic properties of human arteries].
    Mégnien JL; Simon A; Valensi P; Pithois-Merli I; Assad N; Attali J; Levenson J
    Arch Mal Coeur Vaiss; 1991 Aug; 84(8):1101-3. PubMed ID: 1953257
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of calcium antagonists in the treatment of essential hypertension.
    Klein W; Brandt D; Vrecko K; Härringer M
    Circ Res; 1983 Feb; 52(2 Pt 2):I174-81. PubMed ID: 6831651
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cardiovascular profile of oxodipine, a novel dihydropyridine calcium channel blocker, in anesthetized open-chest dogs: a comparison with nitrendipine.
    Alloui A; Talmant JM; Duchêne-Marullaz P
    Arch Int Pharmacodyn Ther; 1991; 313():63-75. PubMed ID: 1816765
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Beneficial effect of T-type calcium channel blockers on endothelial function in patients with essential hypertension.
    Oshima T; Ozono R; Yano Y; Higashi Y; Teragawa H; Miho N; Ishida T; Ishida M; Yoshizumi M; Kambe M
    Hypertens Res; 2005 Nov; 28(11):889-94. PubMed ID: 16555577
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nitrendipine reverses vasoconstriction and renal hemodynamic changes in experimental hypertension.
    Sterzel RB; Huelsemann JL; McKenzie DE; Wilcox CS
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1024-7. PubMed ID: 6085360
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Verapamil and nitrendipine in beta blocker-resistant hypertensive patients].
    Edmonds D; Förster E; Wehling M; Siegenthaler W; Vetter W
    Schweiz Rundsch Med Prax; 1985 May; 74(19):510-3. PubMed ID: 3160098
    [No Abstract]   [Full Text] [Related]  

  • 55. Pharmacological studies of the antihypertensive effect of nitrendipine.
    Stoepel K; Heise A; Kazda S
    Arzneimittelforschung; 1981; 31(12):2056-61. PubMed ID: 7199297
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Calcium antagonists in the treatment of chronic arterial hypertension and hypertensive crisis].
    Brandt D
    Wien Med Wochenschr; 1983 Mar; 133(6):131-5. PubMed ID: 6134398
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Amlodipine compared to nitrendipine in hypertensive patients: the effects on toleration in relationship to the onset of action.
    Waeber B; Borges ET; Christeler P; Guillaume-Gentil M; Hollenstein U; Mannhart M
    Cardiology; 1992; 80 Suppl 1():46-53. PubMed ID: 1534715
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nitrendipine in hypertension that is difficult to control.
    Höffler D; Stoepel K
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1060-2. PubMed ID: 6085367
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Comparative hemodynamic effects of 2 vasodilators: dihydralazine and diltiazem in permanent essential arterial hypertension].
    Levenson J; Simon A; Achimastos A; Temmar M; Safar M
    Arch Mal Coeur Vaiss; 1982 Jun; 75 Spec No():167-70. PubMed ID: 6810821
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Age related antihypertensive effect of nitrendipine, a new calcium entry blocking agent.
    Ferrara LA; Fasano ML; Soro S
    Eur J Clin Pharmacol; 1985; 28(4):473-4. PubMed ID: 3161743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.